CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
Abstract Most genetic alterations that drive melanoma development and resistance to targeted therapy have been uncovered. In contrast, and despite their increasingly recognized contribution, little is known about the non‐genetic mechanisms that drive these processes. Here, we performed in vivo gain‐...
Main Authors: | Arthur Gautron, Laura Bachelot, Marc Aubry, Delphine Leclerc, Anaïs M Quéméner, Sébastien Corre, Florian Rambow, Anaïs Paris, Nina Tardif, Héloïse M Leclair, Oskar Marin‐Bejar, Cédric Coulouarn, Jean‐Christophe Marine, Marie‐Dominique Galibert, David Gilot |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.202013466 |
Similar Items
-
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors
by: Héloïse M. Leclair, et al.
Published: (2020-07-01) -
AhR and Cancer: From Gene Profiling to Targeted Therapy
by: Anaïs Paris, et al.
Published: (2021-01-01) -
Transcriptome Analysis Reveals the AhR, Smad2/3, and HIF-1α Pathways as the Mechanism of Ochratoxin A Toxicity in Kidney Cells
by: Min Cheol Pyo, et al.
Published: (2021-03-01) -
Specific Eph receptor-cytoplasmic effector signaling mediated by SAM–SAM domain interactions
by: Yue Wang, et al.
Published: (2018-05-01) -
Introduction to Sam Gillespie
by: Sigi Jöttkandt
Published: (2006-10-01)